Samarth Kulkarni - Chief Executive Officer, Crispr Therapeutics Ag
As of March 14, 2022
Samarth Kulkarni Net Worth
- Net worth is estimated to be at least $30.74M
- Owns at least 187,719 units of Crispr Therapeutics Ag stock
- Sold an estimated value of $25.46M in the last 5 years at Crispr Therapeutics Ag
Samarth Kulkarni Trading
- Largest purchase of shares was 30,000 units , worth over $377.1K on August 6, 2021
- Largest sale of shares was 20,000 units , worth over $4.27M on January 20, 2021
- In total has made about 46 transactions over 5 years
- Usually trades in December, with the busiest year in 2021
Samarth Kulkarni
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
Samarth Kulkarni Mailing Address
- Mailing address is C/o Crispr Therapeutics Ag 200 Sidney Street Cambridge MA 02139 MA
Crispr Therapeutics Ag Insider Trading
- The most recent transaction was 25,000 units sold on August 10, 2021 by John Michael Tomsicek worth over $3.46M
- In the last 5 years, insiders at Crispr Therapeutics Ag sold an estimated value of $383.13M and bought an estimated value of $55.06M
- The most active traders are Samarth Kulkarni, Chief Executive Officer, Bradley Bolzon, Director, and Rodger Novak, President
- Insider trading is most common in June, with the busiest year in 2017
CRISPR Therapeutics AG Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |